I’ve revised my trading rules for shares to include changes in practice I’ve made over the past few weeks. These rules, as well as those for options, are available from the Trading Rules tab at the top of any page.

Mid-Risk: Share Trades

This strategy relies on a rule-based evaluation for the selection of stocks and on a 20% trailing stop/loss for the exit signal.

I divide my holdings and trading decisions into portfolios, depending upon the method used to evaluate potential additions.

My portfolios are divided into two sorts.

Strategy portfolios use a search of a category of stocks for a symbol that meets certain criteria corresponding with a strategy. I have three strategies that I use:

• Growth, which relies on ratings changes given my market analysts.
• Momentum, which relies on the rate of change over several lengths of time.
• Value, which relies on the financial performance of the company compared to the price of its stock.

A second sort of portfolio, a watchlist portfolio, takes a relatively small list of stocks and trades those that meet general criteria according to one system or another.

For example, my Genetics Portfolio was constructed based on the ARKG exchange-traded funds holdings.

Depending upon the rules, all of this can be done by the trader without relying on the analysis of others. For convenience, I’ve chosen to rely on the analysis aggregator Zacks  to provide the ratings of stocks that I use in making decisions.

Zacks uses analyst ratings on their primary method, using earnings forecasts to select from their already screened pool. Their method boils everything down to a numerical rank: 1 for strong buy, 2 for buy, 3 for neutral, 4 for sell and 5 for strong sell. The rating is relative: The top 5% of their stock pool gets a 1 ranks, as does the bottom 5%. The 2 and 4 ranks each get 15% of the pool, and the 3 rank gets the remaining 60%. So the ranks aren’t objectively good or bad, but only in relation to the rest of the approximately 10,000 stocks the company tracks.

For my strategy portfolios, I require that stocks have a Zacks rank of 1 for entry, and I exit that day if it drops away from the strong buy level. For my watchlist portfolios, I’ll requires a Zacks 1 or 2 rank for entry, with exit rules if that changes to a neutral or sell rank.

Trading Rules

Entry

1. When the Zacks criteria are met.
   1. Strategy portfolios, which are the results of queries into the Zacks database: When the stock appears on the screening, meaning it matches all of my search criteria.
   2. Watchlist portfolios, which are lists of stocks: When a stock on the watchlist has a Zacks rank of 1 or 2.
   3. Income portfolios: When the fund has a Zacks rank of 1, 2 or 3.

Exit

1. Set a trailing stop/loss for each position of 20%.
2. A position that fails to qualify for its portfolio is benched if
   1. the Zacks rank is 1 or 2 (strong buy or buy).
   2. the rank is 3 (hold) and, in the case of a Value, Growth or Momentum portfolio, the corresponding strategy score is A, B or C. (the scale runs from A — best — down to F — worst).
   3. the rank is 3 and, in the case of a watchlist portfolio, such as Genetics or Robotics, the corresponding strategy score for Momentum  and Growth is A, B or C.
3. Otherwise, the Portfolio is exited.

Note that the 20% trailing stop rule was based on three research papers:

Han, Yufeng and Zhou, Guofu and Zhu, Yingzi, Taming Momentum Crashes: A Simple Stop-Loss Strategy (September 24, 2016). Available at SSRN: https://ssrn.com/abstract=2407199 or http://dx.doi.org/10.2139/ssrn.2407199

Yusupov, Garib and Shorrason, Bergsveinn, Performance of Stop-Loss Rules vs. Buy-and-Hold Strategy (2009). Available at Lund University: https://www.lunduniversity.lu.se/lup/publication/1474565

Kaminski, Kathryn and Lo, Andrew W., When Do Stop-Loss Rules Stop Losses? (January 3, 2007). EFA 2007 Ljubljana Meetings Paper. Available at SSRN: https://ssrn.com/abstract=968338 or http://dx.doi.org/10.2139/ssrn.968338

The Zacks rank method presents trades almost every day, as stocks fail to qualify and new stocks qualify to take their place. A no-commission brokerage, which includes the pioneering Robinhood and the major brokerages such as E-Trade and TD Ameritrade that have followed in Robinhood’s footsteps, makes such rapid trading possible. A brokerage that charges commissions would require a different approach.

Zacks makes its ranks for individual stocks freely available, and that is sufficient for managing a small watchlist portfolio.

For example, in creating my Genetics Portfolio, I took the holdings of the ARKG exchange-traded fund — 37 stocks — and within Zacks created a portfolio containing those symbols. The portfolio includes up-to-date rankings for each symbol. Just by pulling up the portfolio and sorting on rank, I can instantly see what the tradable stocks are and compare it with what I already hold. At this writing I hold all nine qualifying stocks.

For my strategy portfolios, which scans the entirely of the massive Zacks stock pool, it’s necessary that I be able to run queries against their databased, and for that I need a premium account, costing an annual subscription of $249. Traders with small accounts will do better by using the watchlist method, thereby avoiding the overhead.

The subscription works out to $20.75 a month, and I’ve entered about 30 positions in the current month, so divide by 60 — once for entry and again for exit — and it works out to a 35 cent premium per trade. Not such a bad deal, considering that in the bad old days of last spring, the commissions would have been at least $13 total for each position.

By Tim Bovee, Portland, Oregon, February 4, 2020

Read More »

11:40 a.m. New York time

I exited my short iron condor options position on XLI and have updated the the analysis with results.  Of the remaining options positions expiring February 21XLE and XLK have in-the-money components, putting them at risk of early assignment, and EEM and TLT are both out of the money.

In stocks trading, the focus portfolio today is Value, and I entered two positions. I also exited a position from Genetics.

I’m making more use of the Bench for positions that have dropped off their portfolios but still have potential value. The result, I hope, will be to reduce the churn in my holdings while maintaining profitability. January was profitable, with 104 completed trades, but I would have done better and had less work with 13-week Treasury Bills.

The rules go like this:

A position that fails to qualify for its portfolio is benched if

• • • the Zacks rank is 1 or 2 (strong buy or buy).
    • the rank is 3 (hold) and, in the case of a Value, Growth or Momentum portfolio, the corresponding strategy score is A, B or C. (the scale runs from A — best — down to F — worst).
    • the rank is 3 and, in the case of a watchlist portfolio, such as Genetics or Robotics, the corresponding strategy score for Momentum  and Growth is A, B or C.

Otherwise, the Portfolio is exited.

 Stock Trades

• Value Portfolio
  • Entries
    • IMTKA, for a $42.83 debit.
    • MOD, a $7.87 debit.
• Genetics
  • Exit
    • RUBY, for a $7.81 credit, for a 23 cent profit per share. The return was 2.9% over one day for a 1,066% annual rate. RUBY’s Zacks rank had dropped to 3 (hold). The score for Momentum was C, which is acceptable, but for Growth was F, which pushed the position into the sell category.
  • Growth
    • Benched
      • AMED was transferred to the Bench, with a Zacks rank of 2 (buy) and a Growth score of A.
  • Momentum
    • Benched
      • CYH, rank of 1 (strong buy), Momentum score C.
  • Robotics
    • Benched
      • SPLK, rank of 1 (strong buy), Growth score of D, Momentum Score F. Note that despite the awful scores, under my rules I kept the position because of the high Zacks rank.

By Tim Bovee, Portland, Oregon, February 4, 2020

Read More »

2:50 p.m. New York time

I’ve exited my share position in PNW for a $98.13 credit, up $6.47 per share from the entry price, producing a 7.9% return over 21 days, or an 138% annual rate.

PNW was part of the now defunct Utilities Portfolio originally. I moved it to the Bench in order to capture the $0.7925 per share dividend, which is included in the return. PNW at this point has a sell (4) score from Zacks.

And it’s departure clears the Bench.

1:20 p.m. New York time

I’ve updated XBI Analysis with results.

11:35 a.m. New York time

I exited my XBI short iron condor this morning for 12.3% of maximum potential profit. I shall update the analysis with results later today.

Two of my short iron condor options positions have options that are in the money. If they are still ITM in expiration week, which begins February 17, then I shall exit the leg at risk of assignment.

• The EEM and XLE short iron condors are in the money on the put side. Exiting the short and long puts would leave bear call spreads for the last few days before expiration.
• TLT and XLK are in the money on the call side. Exiting the calls leaves bull put spreads.

Assuming they remain out of the money, the spreads would expire without value, for maximum profit.

The XLI and XLK short iron condors remain out of the money, although, like everything else, that could change.

On the shares side of my trading, I’ve ended my experiment with trailing stop/loss based on a multiple of the Wilder’s Average True Range, reverting to a trailing 20% stop/loss. A study of the January trades using double the ATR showed about a 50% chance each of an position rising after exit or falling with a double ATR trailing stop.

The tighter stop produced many more trades, resulting from stopped positions, than the 20% trailing did. I’m seeing little advantage from a lot more work. So I’ll set an stop with enough distance to reduce the likelihood of a triggered sale, yet close enough to my entry point so as to not break the bank if things go seriously wrong.

With the more forgiving stop/loss strategy, I had no positions stopped this morning. I entered three positions in today’s focus portfolio.

Stock Trades

• Genetics Portfolio
  • Entries
    • AAPL, for a $312.08 debit.
    • GH, a $76.14 debit.
    • RUBY, a $7.81 debit.

By Tim Bovee, Portland, Oregon, February 3, 2020

Read More »

4:05 p.m. New York time

And the markets close, with no fill on my exit order for the XBI short iron condor.

3:25 p.m. New York time

I’ve updated my XLV short iron condor analysis with results.

3 p.m. New York time

My exit order on my short iron condor on XLY was filled, and I’ve updated the analysis with results.

XLV was just filled, and I shall turn to that next. I also have an exit order on XBI for 4.7% of maximum potential profit, yet unfilled.

1:10 p.m. New York time

Two more stop/losses on stocks were triggered, both of them set at double the Wilder Average True Range.

• Growth Portfolio
  • Exit
    • RH, for a $212.26 credit, down $10.90 per share from the price at entry, producing a 4.9% loss over 10 days for -178% annual rate.
• Genetics
  • Exit
    • SYRS, a $6.81 credit, down $1.61, for a 19.1% loss over 17 days, a -411% annual rate.

11:20 a.m. New York time

We’re 21 days out from expiration of my current options series, and by rules, this is when I cash in my winners. I include trading fees in determining whether or not a position is winning.

All of my positions are short iron condors expiring February 21.

I’ve placed exit orders on  XLV and XLY, the only two clear winners in the batch. No fills as of yet. XLV is at 19% of maximum potential profit, and XLY, at 9%.

XLI is a penny below the credit I received at entry, which places it at 2.2% of maximum potential profit, without considering fees. I’m going to treat it as a loser today and see what develops.

The absolute losers, at present, are EEM, TLT, XBI, XLE and XLK. Two of them, EEM and XLE, are below their profit ranges, and TLT is above its profit range.

The positions I don’t exit today move to sudden death mode, meaning that I sell them when they become profitable enough to at least cover my trading fees.

I’ll have results on the two that I’m exiting today as soon as the orders are filled.

10:40 a.m. New York time

Today’s focus portfolio for stocks is Growth.

I exited three positions today, two of them — KBH and GPX — through a stops. I entered three positions in the in the Growth Portfolio.

Stock Trades

• Growth Portfolio
  • Entries
    • AMED, for a $181.33 debit.
    • IBTX, a $53.64 debit.
    • PHM, a $45.52 debit.
• Value Portfolio
  • Exits
    • GPX, for a $13.77 credit per share, down $1.19 from entry for a 8.0% loss over 14 days, a -207% annual rate.
    • SANM, a $32.14 credit, down $1.09 from entry, producing a 3.3% loss over two days for a -597% annual rate.
• Momentum Portfolio
  • Exit
    • KBH, for a $38.11 credit, down 55 cents from entry for a 1.4% loss over three days, a -173% annual rate.

By Tim Bovee, Portland, Oregon, January 31, 2020

Read More »

1:10 p.m. New York time

I manage my options 21 days before expiration, a practice shown to increase the likelihood of a winning trade, according to research conducted by the financial network TastyTrade. What it means practically is that tomorrow — Friday — I shall be exiting my profitable positions built from options expiring February 21, and setting the stops for the unprofitable positions to the price that would make them profitable enough to cover trading fees.

I have eight short iron condor positions built from the Februaries that will be up for management. XBI, XLI, XLV and XLY are profitable today. Two of the unprofitable positions, EEM and XLE, are below their profit zones, and two others, TLT and and XLK, are above.

Heretofore it has been unusual for half of my positions to remain open past Management Day.

It was a somewhat volatile day for my share holdings, with three positions — WCC, SNX and AES — hitting their stop/losses, and four ceasing to qualify for their portfolios. The focus portfolio today was Robotics, and I added three positions.

Stock Trades

• Value Portfolio
  • Exits
    • OVV, for a $15.86 credit per share, down 93 cents from entry, resulting in a 5.5% loss over one day for a -2,011% annual rate.
    • WCC, a $50.58 credit, down $3.45 from entry, a 6.4% loss over six days for a -389% annual rate.
    • SNX, for a $136.34 credit, down $8.15 from entry, producing a -5.6% loss over six days for a -343% annual rate.
• Momentum Portfolio
  • Exits
    • ELVT, a $5.61 credit, up 69 cents from entry, a 14.0% return over three days, or a 1,699% annual rate.
    • SEM, a $23.38 credit, down 95 cents from entry, a 3.9% loss over one day for a -1,425% annual rate.
• Genetics and Robotics portfolios
  • Exit
    • AAPL, for a $320.69 credit, up $6.83 from the price at entry, producing a 2.2% return over two days, or a 397% annual rate.
• Robotics Portfolio
  • Entries
    • SNPS, for a $149.13 debit per share.
    • SPLK, a $156.86 debit.
    • TCEH, a $48.19 debit.
• Utilities Portfolio
  • Exit
    • AES, which, after becoming disqualified from its portfolio, had been on the Bench awaiting an ex-dividend date, for a $19.98 credit, down 34 cents from entry, for 1.7% loss over 17 days, a -36% annual rate.

By Tim Bovee, Portland, Oregon, January 30, 2020

Read More »

2:40 p.m. New York time

I’ve entered an additional stock position, in  SEM, to fill the position held by FRTA, which I exited today. I bought SEM for a debit of 24.33 per share.

11:40 a.m. New York time

In stocks, today’s focus portfolio is Value, and I entered three positions. I also exited one position each from Momentum and Robotics as they no longer qualified.

Stock Trades

• Value Portfolio
  • Entries
    • BRY, for a $6.98 debit per share.
    • OVV, a $16.79 debit.
    • SANM, a $33.23 debit.
• Momentum Portfolio
  • Exit
    • FRTA, a two-day whipsaw, for a credit of $13.71 per share, down 61 cents from the entry price, producing a 4.3% loss over two days for a -777% annual rate. There was no obvious news to explain the drop.
• Robotics Portfolio
  • Exit
    • ADSK, a $199.49 credit, up $3.11 from entry, producing a 1.6% return over one day for a 579% annual rate.
  •  Entry
    • TSM, a $57.11 debit.

By Tim Bovee, Portland, Oregon, January 29, 2020

Read More »

10:30 a.m. New York time

My options positions, which will reach Management Day on Friday, have improved considerably since yesterday’s market-wide decline. Out of eight positions expiring in February, four are profitable and, if that continues, will be sold on Friday. Four are unprofitable, and I’ll hang on to each of them until it becomes profitable or we’re close to expiration. Only one of the four, XLE, is beyond its profit zone. The underlying is trading for $55.53 at present, and the put strike is at $56.21.

The positions, all of them short iron condors, are on EEM, TLT, XBI, XLE, XLI, XLK, XLV and XLY.

In stocks, today’s focus is on the Genetics Portfolio. There were no exits. I opened five new positions in several portfolios, taking care to ensure that each was in an uptrend as well as meeting my other criteria. In terms of portfolios, the new positions are all over the map.

Stock Trades

• Genetics Portfolio
  • Entries
    • AAPL, for a $313.86 debit per share.
    • EDIT, a $28.99 debit.
• Robotics Portfolio
  • Entries
    • ADSK, a $196.38 debit.
• Momentum
  • Entries
    • KBH, a $38.66 debit.
• Income
  • Entries
    • JCAP, a real estate investment trust with a buy score from Zacks and a 7% dividend, for a $20.02 debit.

By Tim Bovee, Portland, Oregon, January 28, 2020

Read More »

11:50 a.m. New York time

As the world knows, today began as a down day in the markets. I awoke this morning to the gentle clanging of stop/losses triggering on seven of my stock holdings. My options holdings were giving silent screens of pain as they moved away from profitability five days before I’m scheduled to exit the profitable positions.

The Wuhan coronavirus panic has been blamed for the declines. Given the history of the markets over the past year, I’m more inclined to think that the long-awaited major correction is stepping forward. But January honors the Roman god Janus, who is said to have adapted, trading in his double face — Peace or War — for the 21st century’s great concerns: Bull market or Bear. So perhaps the never-ending bull market written by the trading algorithms has not ended yet.

Today’s focus portfolio is Momentum, and a quick check while sipping morning tea — Japanese Bancha, my favorite — I discovered that SNE had dropped off of the Momentum Portfolio, requiring that it be sold. All in all, way too exciting for a Monday morning.

I found three candidates in the Momentum screen that also were still in their uptrends, and I added them to the portfolio.

Today’s exits, combined with those last week left me a with wheelbarrow of free cash and no obviously good place to park it. As always, research will solve that problem.

In the trades below, SNE dropped off the Momentum screen and was manually sold, AAPL exited when its trailing 2% stop/loss was triggered, and the rest had my standard trialing stop/loss that was triggered, set at double the Average True Range.

Stock Trades

• Growth
  • Exits
    • CRMT, for a $106.28 credit per share, down $3.33 from entry, a 3.0% loss over six days for a -185% annual rate.
    • LHCG, a $144.40 credit, up $0.78 from entry, a 0.5% return for a +12% annual rate.
    • YY, a $56.50 credit, down $7.47 from entry, an 11.7% loss over six days for a -711% annual rate.
• Momentum
  • Exits
    • MX, a $14.36 credit,  down $1.56 from entry, a -9.8% loss over five days for a -717% annual rate
    • SNE, a $71.43 credit, up 0.83, showing a 1.2% return over 19 days for a +23% annual rate
  • Entries
    • CVH, a $4.51 per share debit.
    • ELVT, a $4.93 debit.
    • FRTA, a $14.32 debit.
•  Genetics
  • Exit
    • AAPL, a $309.07 credit, up $17.17 from entry, producing a 5.9% return over 27 days for an +80% annual rate.
• Robotics
  • Exits
    • CSOD, a $59.41 credit, down $3.09 from entry, a 3.0% loss over four days for a -441% annual rate.
    • TSM, a $55.52 credit, down $1.70 from entry, a -3.0% loss over four days for a -272% annual rate.

By Tim Bovee, Portland, Oregon, January 27, 2020

Read More »

3:15 p.m. New York time

Additional stop/losses have been triggered. APAM in Momentum and EIX in Utilities had tight stops because they no longer qualified for their portfolios. SYNA had the standard twice the Average True Range for a stop, and HYG — my vehicle for junk-bond income — had a long-standing fixed stop that was triggered after a four-day decline in price.

The details:

• Momentum Portfolio
  • Exits
    • APAM, a $33.59 credit, down 96 cents from entry, producing a 2.8% loss over nine days for a -113% annual rate.
    • SYNA, a $71.04 credit, up $1.49 from entry, for a 2.1% return over 17 days for a +46% annual rate.
• Utilities Portfolio
  • Exit
    • EIX, for a $77.20 credit, up 23 cents from entry, or a 0.3% return over eight days for a 14% annual rate.
• Bond Income
  • Exit
    • HYG, for an $87.72 credit, up 79 cents, excluding dividends. With dividends included, the position produced a 3.3% return over 185 days, or a 7% annual rate.

2:15 p.m. New York time

Of my eight short iron condor positions expiring February 21, all are well below my management point, which is 50% of maximum potential profit. Two are unprofitable and trading above the breakeven point (TLT and XLK). One other is also unprofitable but trading within the profit zone (XLE). Five are profitable at the present (EEM, XBI, XLI, XLV and XLY).

The positions reach 21 days before expiration on Friday of next week, and at that point I’ll exit all positions that are profitable, even if minimally so, a manage-early practice shown by TastyTrade research to improve results.

In stocks, I moved the stop/losses of the positions to double the Average True Range, or closer in a few cases. And sure enough, three positions — EDIT in the Genetics Portfolio, TER in Robotics and VIPS on the Bench — all triggered their stop/losses. Only TER had the standard double ATR stop. EDIT and VIPS each had a single ATR stop.

Two positions no longer qualified for their portfolios. I tightened the trailing stops for APAM in the Momentum Portfolio and EIX in Utilities, since both were trending upward. When EIX exits, it will be the last position in Utilities, which I shall then discontinue.

I sold three other positions. And I entered three, all in the Values Portfolio, which is the focus portfolio for the day.

Stock Trades

• Value Portfolio
  • Entries
    • RUSH, for a $43.66 debit.
    • SNX, a $144.49 debit.
    • WCC, a $54.03 debit.
• Momentum Portfolio
  • Exit
    • MS, for a $54.4 credit, down $1.71 from the entry level, producing a 3.0% loss over two days for a -556% annual rate.
• Genetics Portfolio
  • Exits
    • CDXS for a $17.12 credit, down 18 cents from entry, resulting in a 1.0% loss over one day for a 372% annual rate.
    • EDIT, a $31.79 credit, down $3.78 from entry for an 11.9% loss and a -434% annual rate.
    • REGN, a $345.07 credit, down $14.49 from entry, a 4.0% loss for a 1,471% annual rate.
• Bench Portfolio
  • Exit
    • VIPS for a $13.64 credit, down $1.61 from entry, producing a -10.6% loss, or a -351% annual rate.

By Tim Bovee, Portland, Oregon, January 24, 2020

Read More »

Update 2/4/2020: Note that this method of exiting created problems and I have abandoned it. See the new Trading Rules explanation on the pulldown menu at the top of any page.

---

1:10 p.m. New York time

Today was taking out the trash day, as I cleared out some positions from the Bench that no longer had a reason for being there. And it turned out to be a down day on the markets generally, so there were mainly losses.

I’ve reworked my stock trading rules to bring them into line with my current practices, adding a few new things along the way. Here they are:

1. 1. 1. Entry
         1. When the Zacks criteria are met.
            1. Strategy portfolios, which are the results of queries into the Zacks database: When the stock appears on the screening, meaning it matches all of my search criteria.
            2. Watchlist portfolios, which are lists of stocks: When a stock on the watchlist has a Zacks rank of 1 or 2.
            3. Income portfolios: When the fund has a Zacks rank of 1, 2 or 3.
         2. Set a trailing stop/loss for each position.
            1. 1. The standard stop/loss will be set at double the 14-day Wilder Average True Range at the time the stop is set.
               2. The stop/loss can be varied to meet the needs of a position.

1. 1. 2. Position Management
         1. Exit each position that fails to meet the criteria of its portfolio.

1. 1. 1. 1. 1. In exiting, consider setting a close trailing stop/loss rather than exiting outright, in case the position rises.
            2. A position that no longer meets the criteria of its portfolio may be moved to the Bench if there is a reason to continue to hold it, such as an ex-dividend date in the near future.

The biggest change is the trailing stop/loss requirement. I’ll be updating the Trading Rules section with these changes over the weekend.

Today’s focus was on the watchlist portfolios. I’m in the process of phasing out the Utilities Portfolio, replacing it with a Robotics Portfolio based on the holdings of the ARKQ exchange-traded fund, which also manages the ARKG fund, the source of the watchlist for my Genetics Portfolio (although ARKG calls it “genomics”).

Today’s Trades

• Genetics
  • Entries
    • CDXS, for a $17.29 debit.
    • REGN, a $359.56 debit.
• Robotics
  • Entries
    • CSOD, for a $62.43 debit.
    • TER, a $76.15 debit.
    • TSM, a $57.22 debit
• Growth
  • Exits
    • AMED, for a $180.64 credit per share, down 31 cents from the entry level, a 0.2% loss over two days for a -31% annual rate.
    • ATSG, a $21.53 credit, down $1.64, for a 7.1% loss over 20 days, a a -129% annual rate.
    • NTAP, a $59.99 credit, down $1.65, producing a 2.7% loss over two days for a -489% annual rate.
• Momentum
  • Exits
    • PERI, for a $9.06 credit, down 56 cents from the entry level, producing a 5.8% loss over one day for a -2,125% annual rate.
• Bench
  • Exits
    • NGLOY, for a $14.06 credit per shares, up two cents from the entry level, producing a 0.1% return over 20 days for a 2.6% annual rate.
    •  PFGC, a $51.87 credit, down 23 cents, a 0.5% loss over 16 days for a -10% annual rate.
    • TALO, a $25.88 credit, down $5.11 from entry, a 16.5% loss over 16 days for a -376% annual rate.
    • TNK, a $20.02 credit, down $3.77 from entry, a 15.9% loss over nine days for a -643% annual rate.

By Tim Bovee, Portland, Oregon, January 23, 2020

Read More »